We found fairly similar results for GFAP and NfL in the association of the neurodegenerative biomarkers with dementia in both countries; those with higher levels of GFAP and NfL were more likely to have dementia both in the individual models and the combined models in both countries (Figure 5, Table S4). The gene discussed is GFAP; the disease is dementia.